TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $26K of Entrada Therapeutics, Inc.
Sold$26,282
$14.95Price
1,758Shares
−2%Stake
What TRDA did after the filing
- The stock from Wed, Jul 10 close, $15.74
- +4.6%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Aug 21 close.
Traded Mon, Jul 8. Filed Wed, Jul 10, 12:34 PM ET, during the session. Returns use the Jul 10 close and the Aug 21 close. Not investment advice.